K. Siler

发表

Advantage of dose fractionation in monoclonal antibody-targeted radioimmunotherapy.

J. Schlom, A. Molinolo, J. Simpson, 1990, Journal of the National Cancer Institute.

Lymphomas and leukemias in the relatives of patients with mycosis fungoides

M. Greene, J. Kant, H. Pinto, 1982, Cancer.

Tumor targeting with monoclonal antibody B72.3: experimental and clinical results.

A. Thor, J. Schlom, J. Carrasquillo, 1990, Cancer treatment and research.

Clinical comparison of radiolocalization of two monoclonal antibodies (mAbs) against the TAG-72 antigen.

A. Scott, R. Finn, C. Divgi, 1994, Nuclear medicine and biology.

Concepts in the delivery of monoclonal antibodies in the targeting of human carcinomas

S. Larson, J. Schlom, J. Carrasquillo, 1988 .

Phase I radioimmunotherapy trial with iodine-131-CC49 in metastatic colon carcinoma.

S. Larson, A. Scott, N. Kemeny, 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Biodistribution and preclinical radioimmunotherapy studies using radiolanthanide‐labeled immunoconjugates

J. Schlom, M. Schott, D. Milenic, 1994, Cancer.

Therapeutic efficacy of a high-affinity anticarcinoembryonic antigen monoclonal antibody (COL-1).

P. Hand, J. Schlom, D. Milenic, 1993, Biotechnology therapeutics.

Binding of radiolabeled MAb B72.3 administered intravenously and intraperitoneally in colorectal cancer patients. An overview.

S. Larson, J. Schlom, J. Carrasquillo, 1990, Acta radiologica. Supplementum.

Monoclonal antibody-based therapy of a human tumor xenograft with a 177lutetium-labeled immunoconjugate.

J. Schlom, D. Milenic, D. Houchens, 1991, Cancer research.

Diet-induced alterations in the discoid shape and phospholipid fatty acid compositions of rat erythrocytes

E. Larkin, K. Siler, G. Ananda Rao, 2006, Lipids.

Response of the rat erythrocyte to ozone exposure.

S. Kimzey, E. Larkin, K. Siler, 1978, Journal of applied physiology: respiratory, environmental and exercise physiology.

Therapeutic advantage of high-affinity anticarcinoma radioimmunoconjugates.

J. Schlom, A. Molinolo, D. Houchens, 1992, Cancer research.

Radiolabeled monoclonal antibody B72.3 localization in metastatic lesions of colorectal cancer patients.

S. Larson, J. Schlom, J. Carrasquillo, 1987, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

Phase I trial of iodine 131-labeled COL-1 in patients with gastrointestinal malignancies: influence of serum carcinoembryonic antigen and tumor bulk on pharmacokinetics.

G. Curt, J. Schlom, J. Grem, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Monoclonal antibody-based therapy of a human tumor xenograft with a 177lutetium-labeled immunoconjugate.

D. Milenic, D. Colcher, K. Siler, 1991, Cancer research.